Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Wolfgang Müller‐Felber et al.|The Lancet Neurology|2024Cited by 128
Myelin protein zero mutation‐related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohortJuliane Bremer, Joachim Weis, Axel Meinhardt et al.|Brain Pathology|2023Cited by 12
686VPThorough QT study on the effect of therapeutic and supratherapeutic dosing of givinostat in healthy volunteersTracey Willis, S. Cazzaniga, E. Mercuri et al.|Neuromuscular Disorders|2025Cited by 0